Artiva Biotherapeutics (ARTV) Enterprise Value: -6.294M

Artiva Biotherapeutics, Inc. (ARTV)

6.65 -0.18 (-2.64%) USD | NASDAQ | Oct 05, 10:48

Enterprise Value Chart

Historical Enterprise Value Data

View and export this data back to 2024. Start Trial.

Date	Value
October 02, 2026	-6.294M
October 01, 2026	-8.245M
September 30, 2026	7.856M
September 29, 2026	3.465M
September 28, 2026	4.441M
September 25, 2026	1.513M
September 24, 2026	25.91M
September 23, 2026	37.13M
September 22, 2026	55.18M
September 21, 2026	42.50M
September 18, 2026	80.56M
September 17, 2026	72.26M
September 16, 2026	80.07M
September 15, 2026	95.19M
September 14, 2026	155.21M
September 11, 2026	159.11M
September 10, 2026	168.87M
September 09, 2026	186.92M
September 08, 2026	191.32M
September 04, 2026	206.44M
September 03, 2026	203.27M
September 02, 2026	212.30M
September 01, 2026	210.83M
August 31, 2026	211.81M
August 28, 2026	201.56M

Date	Value
August 27, 2026	243.04M
August 26, 2026	234.74M
August 25, 2026	234.74M
August 24, 2026	222.54M
August 21, 2026	193.75M
August 20, 2026	204.00M
August 19, 2026	231.32M
August 18, 2026	230.35M
August 17, 2026	233.28M
August 14, 2026	219.13M
August 13, 2026	211.81M
August 12, 2026	223.03M
August 11, 2026	235.23M
August 10, 2026	207.90M
August 07, 2026	210.34M
August 06, 2026	225.47M
August 05, 2026	225.96M
August 04, 2026	200.59M
August 03, 2026	185.46M
July 31, 2026	153.26M
July 30, 2026	169.36M
July 29, 2026	149.35M
July 28, 2026	174.24M
July 27, 2026	163.99M
July 24, 2026	149.84M

Enterprise Value Definition

EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.

Read full definition.

Enterprise Value Range, Past 5 Years

View Enterprise Value Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

Enterprise Value Benchmarks

View Enterprise Value Benchmarks